Trial intelligence / Profile preview

Hyoscine Trial in Primigravida Women in Labour

PACTR202409867055348Completed

Sponsor
Self
Start
Apr 2016
Modality
Small Molecules
Countries
1
01

Overview

Trial of hyoscine butylbromide (2 arms), sponsored by Self. Primary endpoints: Rate of cervical dilation, Total duration of first stage of labour and 2 more. Started Apr 2016; status: completed.

02

Drugs

hyoscine butylbromide

Beyond the preview

Go deeper on PACTR202409867055348.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202409867055348.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call